SynthesisJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer.

Jinani Jayasekera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.